Moxetumomab Pasudotox-tdfk and Ramucirumab Intravenous
Determining the interaction of Moxetumomab Pasudotox-tdfk and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Ranexa
- Moxetumomab Pasudotox-tdfk-Ranibizumab
- Moxetumomab Pasudotox-tdfk-Ranibizumab Intraocular
- Moxetumomab Pasudotox-tdfk-Ranibizumab ophthalmic
- Moxetumomab Pasudotox-tdfk-Ranitidine
- Moxetumomab Pasudotox-tdfk-Ranitidine Capsule
- Ramucirumab Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Ramucirumab Intravenous-Moxifloxacin
- Ramucirumab Intravenous-Moxifloxacin (Systemic)
- Ramucirumab Intravenous-Moxifloxacin Hydrochloride
- Ramucirumab Intravenous-Moxifloxacin Injection
- Ramucirumab Intravenous-Moxifloxacin Intravenous